Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc.

2.55
+0.04001.59%
Post-market: 2.550.00000.00%19:58 EDT
Volume:1.09M
Turnover:2.77M
Market Cap:84.32M
PE:-1.90
High:2.58
Open:2.51
Low:2.49
Close:2.51
52wk High:3.84
52wk Low:1.62
Shares:33.07M
Float Shares:24.28M
Volume Ratio:1.14
T/O Rate:4.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3400
EPS(LYR):-2.3605
ROE:-682.61%
ROA:-121.85%
PB:-5.29
PE(LYR):-1.08

Loading ...

NRx Pharmaceuticals announces incorporation of NRx Defense Systems

TIPRANKS
·
Apr 16

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

BUZZ-NRx Pharmaceuticals rises as it launches defense-focused mental health unit

Reuters
·
Apr 15

NRx advances robotic TMS plus D-cycloserine neuroplastic therapy for military, responders

Reuters
·
Apr 15

NRX Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined With Neuroplastic Therapy for Military and First Responder Applications

THOMSON REUTERS
·
Apr 15

NRX Pharmaceuticals Inc: Development Initiative to Be Conducted Through R&D Unit NRX Defense Systems, in Partnership With Zeta Surgical

THOMSON REUTERS
·
Apr 15

NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Appointment of Glenn Tyson as the Company’s First Chief Commercial Officer

THOMSON REUTERS
·
Apr 13

Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer

Dow Jones
·
Apr 13

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application

GlobeNewswire
·
Apr 06

NRx unit Hope Therapeutics partners with Emobot to deploy AI depression monitoring networkwide

Reuters
·
Mar 30

Hope Therapeutics, an NRX Pharmaceuticals Subsidiary (Nasdaq:Nrxp), Announces Strategic Partnership With Emobot to Integrate Its AI-Powered “Depression Thermometer” Across Its Interventional Psychiatry Network

THOMSON REUTERS
·
Mar 30

Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT)

TIPRANKS
·
Mar 25

Nrx Pharmaceuticals: Extensive Clinical, Regulatory, and Financial Risks Make Shares Highly Speculative

TIPRANKS
·
Mar 25

NRX Pharmaceuticals held annual shareholder meeting, investors approved incentive plan amendment

Reuters
·
Mar 25

NRX Pharmaceuticals Price Target Maintained With a $25.00/Share by BTIG

Dow Jones
·
Mar 25

NRX Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 24

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

GlobeNewswire
·
Mar 24

NRX Pharmaceuticals Q4 EPS $0.20 Up From $(0.77) YoY, Sales $983.000K

Benzinga
·
Mar 24

NRx Pharmaceuticals FY 2025 net loss was USD 29 million as interest expense rose 192% to USD 1 million

Reuters
·
Mar 24

NRX Pharmaceuticals Inc expected to post breakeven results a share - Earnings Preview

Reuters
·
Mar 20